Position in LGND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,647,787
+$1,884,631 QoQ
Shares Held
14,704
+6.2% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#109
of 411 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Future Fund LLC holds $27,055,231 across 6 Biotechnology names. LGND ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
142,007 | $11,114,887 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
71,362 | $5,658,292 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
This page
|
14,704 | $4,647,787 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,037 | $2,502,029 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
248,524 | $2,080,145 | |
| 6 | ARGX |
Argenx SE
|
1,134 | $1,052,091 |
All Filings in LGND
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,647,787 | 14,704 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,763,156 | 13,840 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,754,569 | 9,280 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||